Haemonetics Corporation Share Repurchase Authorization
Haemonetics Corporation (HAE) had Share Repurchase Authorization of $300.00 million as of 2022-08-31, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-11-07
- 2022-08-31: Stock Repurchase Program Authorized Amount1 $300.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2022-08-31 | $300.00M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |